Literature DB >> 25877755

MiRNA-494 inhibits metastasis of cervical cancer through Pttg1.

Bing Chen1, Zhaohui Hou1, Chundong Li1, Ying Tong2.   

Abstract

Many cervical cancer (CC) patients experience early cancer metastasis, resulting in poor therapeutic outcome after resection of primary cancer. Hence, there is a compelling requirement for understanding of the molecular mechanisms underlying the invasiveness control of CC. Pituitary tumor-transforming gene 1 (Pttg1) has been recently reported to promote cancer cell growth and metastasis in a number of various tumors. However, its regulation by microRNAs (miRNAs) as well as its role in CC have not been clarified. Here, we reported significantly higher levels of Pttg1 and significantly lower levels of miR-494 in the resected CC tissue, compared with the adjacent normal cervical tissue from the same patient. Interestingly, Pttg1 levels inversely correlated with miR-494 levels. In vitro, Pttg1 levels determined CC cell invasiveness and were inhibited by miR-494 levels. However, miR-494 levels were not affected by Pttg1 levels. Furthermore, miR-494 inhibited Pttg1 expression in CC cells, through directly binding and inhibition on 3'-UTR of Pttg1 mRNA. Together, our data suggest that Pttg1 may increase CC cell metastasis, which is negatively regulated by miR-494. Our work thus highlights a novel molecular regulatory machinery in metastasis of CC.

Entities:  

Keywords:  Cancer metastasis; Cervical cancer; Pituitary tumor-transforming gene 1; miR-494

Mesh:

Substances:

Year:  2015        PMID: 25877755     DOI: 10.1007/s13277-015-3440-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

Review 1.  Rapid growth of cervical cancer metastasis in the brain.

Authors:  P Peters; H Bandi; J Efendy; A Perez-Smith; S Olson
Journal:  J Clin Neurosci       Date:  2010-06-09       Impact factor: 1.961

Review 2.  The emerging role of pituitary tumor transforming gene in tumorigenesis.

Authors:  Jacob Tfelt-Hansen; Deepthi Kanuparthi; Naibedya Chattopadhyay
Journal:  Clin Med Res       Date:  2006-06

3.  Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1.

Authors:  Carolina Castilla; M Luz Flores; Rafael Medina; Begoña Pérez-Valderrama; Francisco Romero; María Tortolero; Miguel A Japón; Carmen Sáez
Journal:  Mol Cancer Ther       Date:  2014-08-13       Impact factor: 6.261

4.  Expression of pituitary tumor transforming gene 1 is an independent factor of poor prognosis in localized or locally advanced prostate cancer cases receiving hormone therapy.

Authors:  Xi-Liang Cao; Jiang-Ping Gao; Wei Wang; Yong Xu; Huai-Yin Shi; Xu Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2012

5.  Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity.

Authors:  D S Kim; J A Franklyn; V E Smith; A L Stratford; H N Pemberton; A Warfield; J C Watkinson; T Ishmail; M J O Wakelam; C J McCabe
Journal:  Carcinogenesis       Date:  2006-10-27       Impact factor: 4.944

6.  Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer.

Authors:  Yasuyuki Shibata; Nobuhiro Haruki; Yoshiyuki Kuwabara; Tadashi Nishiwaki; Joji Kato; Noriyuki Shinoda; Atsushi Sato; Masahiro Kimura; Hiroshi Koyama; Tatsuya Toyama; Hideyuki Ishiguro; Junzo Kudo; Yukio Terashita; Shigeru Konishi; Yoshitaka Fujii
Journal:  Jpn J Clin Oncol       Date:  2002-07       Impact factor: 3.019

7.  Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice.

Authors:  Shivendra V Singh; Anna A Powolny; Silvia D Stan; Dong Xiao; Julie A Arlotti; Renaud Warin; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Douglas M Potter; Rajiv Dhir
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

8.  PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation.

Authors:  Shengquan Huang; Qianjin Liao; Longkun Li; Dianqi Xin
Journal:  Tumour Biol       Date:  2014-03-14

Review 9.  Calcaneal metastasis in uterine cervical cancer: a case report and a review of the literature.

Authors:  T Kanayama; S Mabuchi; M Fujita; T Kimura
Journal:  Eur J Gynaecol Oncol       Date:  2012       Impact factor: 0.196

10.  RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.

Authors:  S Q Huang; Q J Liao; X W Wang; D Q Xin; S X Chen; Q J Wu; G Ye
Journal:  Braz J Med Biol Res       Date:  2012-08-09       Impact factor: 2.590

View more
  16 in total

1.  Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas.

Authors:  Dongxia Fu; Yunna Zhang; Haibin Cui
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

2.  HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway.

Authors:  Wen-Yan Wang; Yun-Xia Cao; Xiao Zhou; Bing Wei; Lei Zhan; Liu-Tao Fu
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

3.  MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD.

Authors:  Baoyou Sun; Lei Li; Wendong Ma; Shikang Wang; Chunjin Huang
Journal:  Tumour Biol       Date:  2015-12-28

4.  Prognostic implications of securin expression and sub-cellular localization in human breast cancer.

Authors:  N Gurvits; H Repo; E Löyttyniemi; M Nykänen; J Anttinen; T Kuopio; K Talvinen; P Kronqvist
Journal:  Cell Oncol (Dordr)       Date:  2016-03-16       Impact factor: 6.730

5.  microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer.

Authors:  Aijun Yang; Xuenan Wang; Chunna Yu; Zhenzhen Jin; Lingxia Wei; Jinghe Cao; Qin Wang; Min Zhang; Lin Zhang; Lei Zhang; Cuifang Hao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

Review 6.  The roles of microRNAs related with progression and metastasis in human cancers.

Authors:  Hai-Ting Liu; Peng Gao
Journal:  Tumour Biol       Date:  2016-10-06

7.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Pituitary tumor-transforming gene 1 enhances metastases of cervical cancer cells through miR-3666-regulated ZEB1.

Authors:  Lin Li; Li-Ying Han; Ming Yu; Qi Zhou; Jian-Cheng Xu; Ping Li
Journal:  Tumour Biol       Date:  2015-09-17

9.  circMYC promotes cell proliferation, metastasis, and glycolysis in cervical cancer by up-regulating MET and sponging miR-577.

Authors:  Zhizhen Wang; Yang Chen; Wei Wang; Hui Wang; Ransheng Liu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

10.  miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.

Authors:  Pingping Tao; Hao Wen; Binlie Yang; Ai Zhang; Xiaohua Wu; Qing Li
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.